153 related articles for article (PubMed ID: 16995847)
1. Immunosuppressive therapy protocols in kidney transplantation in adults.
Karamehić J; Lorber M; Formica R; Gavrankapetanović F; Heljić B; Subasić D; Zecević L
Bosn J Basic Med Sci; 2006 Aug; 6(3):43-7. PubMed ID: 16995847
[TBL] [Abstract][Full Text] [Related]
2. Current concepts and perspectives of immunosuppression in organ transplantation.
Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
[TBL] [Abstract][Full Text] [Related]
3. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
Birkeland SA
Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
[TBL] [Abstract][Full Text] [Related]
4. Immunopharmacologic therapy in renal transplantation.
Shoker AS
Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
[TBL] [Abstract][Full Text] [Related]
5. The impact of age on rejection in kidney transplantation.
de Fijter JW
Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression after kidney transplantation: current stragegies and drug interactions.
Sankari BR; Khauli RB
J Med Liban; 2004; 52(4):234-40. PubMed ID: 16432988
[TBL] [Abstract][Full Text] [Related]
7. Comparison between spousal donor transplantation treated with anti-thymocyte globulin induction therapy and, living related donor transplantation treated with standard immunosuppression.
Demir E; Paydas S; Erken U
Saudi J Kidney Dis Transpl; 2014 May; 25(3):520-3. PubMed ID: 24821146
[TBL] [Abstract][Full Text] [Related]
8. Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation.
Pratschke J; Dragun D; Hauser IA; Horn S; Mueller TF; Schemmer P; Thaiss F
Transplant Rev (Orlando); 2016 Apr; 30(2):77-84. PubMed ID: 26965071
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
Triemer HL; Pearson TC; Odom KL; Larsen CP
Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
[TBL] [Abstract][Full Text] [Related]
10. The next generation of medications for kidney transplant patients.
Sims TW; Good EW
Crit Care Nurs Clin North Am; 2002 Mar; 14(1):99-109. PubMed ID: 11939650
[TBL] [Abstract][Full Text] [Related]
11. Contemporary immunosuppression in renal transplantation.
Luke PP; Jordan ML
Urol Clin North Am; 2001 Nov; 28(4):733-50. PubMed ID: 11791490
[TBL] [Abstract][Full Text] [Related]
12. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].
van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W
Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528
[TBL] [Abstract][Full Text] [Related]
13. Simulect: redefining immunosuppressive strategies.
Moore R
Transplant Proc; 2000 Nov; 32(7):1460-2. PubMed ID: 11119790
[No Abstract] [Full Text] [Related]
14. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney.
Sandovici M; Deelman LE; Benigni A; Henning RH
Adv Drug Deliv Rev; 2010 Nov; 62(14):1358-68. PubMed ID: 20688115
[TBL] [Abstract][Full Text] [Related]
15. Immune System and Kidney Transplantation.
Shrestha BM
JNMA J Nepal Med Assoc; 2017; 56(208):482-6. PubMed ID: 29453486
[TBL] [Abstract][Full Text] [Related]
16. Transplantation: new protocols and new worries.
Grinyo JM
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
[No Abstract] [Full Text] [Related]
17. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
[No Abstract] [Full Text] [Related]
18. Update in immunosuppression.
Huizinga R
Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
[TBL] [Abstract][Full Text] [Related]
19. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.
Ciancio G; Garcia-Morales R; Burke GW; Roth D; Esquenazi V; Tzakis A; Miller J
Transplant Proc; 1999; 31(1-2):679. PubMed ID: 10083291
[No Abstract] [Full Text] [Related]
20. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
